Aug 24, 2022
thINc360 PBM 2.0 Market Insight Panel; Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology
Aug 11, 2022
Next-Gen PBM Capital Rx Becomes a Tech Co: Inside New PBA Biz, $106M Series C & Big Plans with WTF Health
Capital Rx CEO AJ Loiacono discusses how regulatory progress may impact the PBM business with General Catalyst's Holly Maloney.
Capital Rx CEO AJ Loiacono describes the importance of bringing a new system - JUDI® - to the market to process Medicare claims.
Capital Rx CEO AJ Loiacono and General Catalyst's Holly Maloney share 5 predictions for 2023.
Capital Rx CEO AJ Loiacono and General Catalyst's Holly Maloney discuss key investment and management challenges faced in 2022.
What should an ethical PBM look like? Watch AJ Loiacono and MedCity's Arundhati Parmar at ENGAGE at HLTH 2022.
Capital Rx President Matt Gibbs breaks down drug price indexes, including problems with them, and what plan sponsors/payers should be thinking and asking about during contracting.
On May 23, 2022, Capital Rx’s Chief Growth Officer, Kristin Begley, was joined by an exceptional panel of experts on stage at thINc360.
Thanks to Jessica DaMassa and WTF Health for having Capital Rx Co-Founder & CEO, AJ Loiacono, on for a great discussion about the evolution of the pharmacy benefit management (PBM) and pharmacy benefit administration (PBA) models!